Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Nature Communications|April 3, 2026
Non-canonical IL‑22 receptor signaling remodels the oral mucosal barrier during Candida albicans immunosurveillanceNicolas Millet, Jinendiran Sekar, Norma V Solis, et al.
Journal of Clinical Microbiology|March 7, 2025
Clinical significance and antifungal susceptibility profile of 103 clinical isolates of Scedosporium species complex and Lomentospora prolificans obtained from NIH patientsMary M Czech, Jennifer Cuellar-Rodriguez, Kyung J Kwon-Chung, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2022
Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous CandidiasisJigar V Desai, Amanda Urban, Doris Z Swaim, et al.
JCI Insight|February 9, 2018
The homozygous CX3CR1-M280 mutation impairs human monocyte survivalAmanda L Collar, Muthulekha Swamydas, Morgan O'Hayre, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2017
Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of functionElizabeth P Sampaio, Li Ding, Stacey R Rose, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient miceTimothy J Break, Jigar V Desai, Kelley R Healey, et al.
Frontiers in Immunology|February 27, 2023
Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseasesThomas Clarke, Pan Du, Satyendra Kumar, et al.
Science Immunology|May 30, 2025
An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infectionRachael L Philips, Yi-Chu Liao, Colleen M Lau, et al.
Science Immunology|March 21, 2025
GM-CSF-mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatusKathleen A M Mills, Frederike Westermann, Vanessa Espinosa, et al.
Frontiers in Immunology|September 10, 2021
SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED PatientsElise M N Ferré, Monica M Schmitt, Sebastian Ochoa, et al.
Pageof 28